Navigation Links
Genedata Expressionist for Mass Spectrometry Showcased at 2013 Biotherapeutics Analytical Summit
Date:3/12/2013

Baltimore, MD (PRWEB) March 12, 2013

Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that Genedata Expressionist® for Mass Spectrometry will be showcased in the “Establishing Analytical Support for Manufacturing” session of the 2013 Biotherapeutics Analytical Summit. The session will present workflows for analyzing glycosylation events using Genedata Expressionist. The Genedata platform automates and standardizes protein characterization within a single high-throughput system to significantly improve sample throughput and result reproducibility. The presentation will be given on March 13 (Royal Sonesta Harbor Court) by Dr. Monica Lane from Genzyme.

Genedata Expressionist for Mass Spectrometry is a comprehensive, enterprise software solution that efficiently manages, processes and analyzes massive amounts of mass spectrometry data. With a proven track record of success in the biopharmaceutical industry, it analyzes mass spectrometry data for a variety of tasks related to protein characterization, such as identification and quantification of Post Translational Modifications (PTMs). Instrument-agnostic, Genedata Expressionist integrates and analyzes raw data from any mass spectrometry technology and vendor, serving as an integration platform for analytical labs using a variety of mass spectrometry instruments. By automating routine data analysis, Genedata Expressionist has been successfully applied along the biopharmaceutical R&D and manufacturing pipelines to improve quality control and sample analytics.

Standardized Platform Accelerates Research – Reduces Research Costs
Thriving on large experimental data sets, Genedata Expressionist has been proven to reduce data analysis time from weeks to a few hours. By enhancing productivity, improving data quality and accelerating time-to-market, Genedata Expressionist contributes to significant cost savings by several orders of magnitude.

The Genedata session at the Biotherapeutics Analytical Summit will demonstrate how leading pharmaceutical companies have successfully automated the analysis of mass spectrometry data for site-specific glycosylation of biopharmaceuticals. The qualitative and quantitative analysis of glycosylation presents data analysis challenges, which Genedata Expressionist solves with a platform for fast comparability of biotherapeutic batches, ensuring consistent manufacturing processes.

“Genedata Expressionist for Mass Spectrometry provides our customers with a highly valuable platform that automates the processing of mass spec data in the context of characterizing biotherapeutics,” noted Dr. Othmar Pfannes, CEO of Genedata. “In particular, our solution’s innovative visualizations enable quick and reproducible decision making. The elimination of data analysis bottlenecks generates tremendous cost and time savings, making Genedata Expressionist nothing short of a killer application for the bioanalytics industry,” continued Pfannes.

“Establishing Analytical Support for Manufacturing” Session: “Automating Comprehensive Site-Specific Glycosylation Analysis of a Recombinant Glycoprotein Using a Differential Feature-Finding Software Workflow;” March 13, 2013 at 10:05am (Genedata Expressionist for MS).

Genedata Expressionist for Mass Spectrometry Poster Session: Bioanalytical Mass Spectrometry application for sequence identification, quantifying PTMs, intact protein, and host cell protein impurity analysis.

About Genedata
Genedata transforms data into intelligence with a portfolio of advanced software solutions, which make research data accessible and understandable and research processes more efficient. These solutions are used worldwide by leading pharmaceutical, industrial and agricultural biotechnology companies as well as academic research organizations. Genedata innovations enable scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Germany, Japan, and the US. http://www.genedata.com.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10497840.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Ono Pharmaceutical Selects Genedata Expressionist for Mass Spectrometry
2. Genedata Biologics 3.0 Boosts Efficiency Through Standardization
3. Genedata Screener Adopted for all Plate-based Screening by Major Pharmas
4. Genedata Screener for HCS Advances Phenotypic Screening
5. Genedata Expressionist® Established as Data Analysis Platform for Oncological Research
6. Genedata Screener to Present at 10th Annual Ion Channel Retreat
7. Spectrometry Market (Atomic, Molecular and Mass Spectrometry) - Global Scenario, Trends, Industry Analysis, Size, Share & Forecast 2011 - 2017
8. Spectrometry Industry (Atomic, Molecular and Mass Spectrometry) is Expected to Reach USD 15.2 Billion Globally in 2017: Transparency Market Research
9. New laboratory method uses mass spectrometry to rapidly detect staph infections
10. Smith & Nephew Announces Agreement To Acquire Assets Of Healthpoint Biotherapeutics
11. Northwest Biotherapeutics Appoints Pharma Industry Veteran As CEO Of German Subsidiary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2019)... NEW YORK (PRWEB) , ... May 22, 2019 , ... ... it has closed a $8 million Series A funding round co-led by Astanor ... State’s Empire State Development Fund and iSelect Fund . The company ...
(Date:5/15/2019)... ... 16, 2019 , ... Emulsifiers are the magic bullet when ... rely on these ingredients to create stable quality food that can withstand shelf-life ... triggers food formulators to seek out alternatives for starches, gums and chemical emulsifiers. ...
(Date:5/8/2019)... , ... May 07, 2019 , ... Standing at 16.2 hands, Atlas is on the ... in a drill team and barrel racing, among other activities. When loping around a ... He went from being a busy horse to only being able to walk. Fortunately ...
(Date:5/4/2019)... ... May 03, 2019 , ... Diopsys Inc, the world ... Negative Response vision test, a new full field electroretinography (ffERG) protocol designed ... 6.3 million Americans will have glaucoma, with black Americans having the highest prevalence ...
Breaking Biology Technology:
(Date:7/19/2019)... ... 19, 2019 , ... Improved Pharma LLC announces the upcoming ... Synchrotron X-ray Pair Distribution (SXPDF) Studies”. The authors are Stephen R. Byrn and ... Laboratory and Gabriel de Araujo of the University of Sao Paulo. ...
(Date:7/17/2019)... ... 16, 2019 , ... Imagine using a simple, portable test to detect cancer ... causes osteoporosis. For South Dakota School of Mines & Technology researcher Congzhou Wang, Ph.D., ... of our ability to monitor and prevent disease,” says Wang. , Wang, an ...
(Date:7/9/2019)... (PRWEB) , ... July 08, 2019 , ... ... ruled in favor of Danisco’s ownership of the innovation behind two Danisco amylase ... an entitlement action could be based on prior art was without merit and ...
Breaking Biology News(10 mins):